• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为公共利益利用真实世界数据相关的数据治理:英国概述及未来考虑。

Navigating data governance associated with real-world data for public benefit: an overview in the UK and future considerations.

机构信息

Faculty of Medicine and Health, University of Leeds, Leeds, UK

School of Health and Related Research, The University of Sheffield Faculty of Medicine Dentistry and Health, Sheffield, UK.

出版信息

BMJ Open. 2023 Oct 4;13(10):e069925. doi: 10.1136/bmjopen-2022-069925.

DOI:10.1136/bmjopen-2022-069925
PMID:37793928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10551984/
Abstract

Real-world data encompass data primarily captured for the provision or operation of services, for example, electronic health records for direct care purposes, but which may have secondary uses for informing research or commissioning. Public benefit is potentially forfeited by the underutilisation of real-world data for secondary uses, in part due to risk aversion when faced with the prospect of navigating necessary and important data governance processes. Such processes can be perceived as complex, daunting, time-consuming and exposing organisations to risk. By providing an overview description and discussion around the role of six key legal and information governance frameworks and their role regarding responsible data access, linkage and sharing, our intention is to make data governance a less daunting prospect and reduce the perception that it is a barrier to secondary uses, thus enabling public benefit.

摘要

真实世界数据包括主要为提供或运营服务而采集的数据,例如直接护理目的的电子健康记录,但这些数据也可能具有用于为研究或委托提供信息的次要用途。如果未能充分利用真实世界数据的次要用途,则可能会丧失公共利益,部分原因是在面临导航必要和重要的数据治理流程的前景时存在风险规避。这些流程可能被视为复杂、令人生畏、耗时且使组织面临风险。通过提供有关六个关键法律和信息治理框架的角色的概述描述和讨论,以及它们在负责任的数据访问、链接和共享方面的作用,我们的目的是使数据治理不再令人生畏,并减少将其视为次要用途障碍的看法,从而实现公共利益。

相似文献

1
Navigating data governance associated with real-world data for public benefit: an overview in the UK and future considerations.为公共利益利用真实世界数据相关的数据治理:英国概述及未来考虑。
BMJ Open. 2023 Oct 4;13(10):e069925. doi: 10.1136/bmjopen-2022-069925.
2
Public responses to the sharing and linkage of health data for research purposes: a systematic review and thematic synthesis of qualitative studies.公众对用于研究目的的健康数据共享和关联的反应:定性研究的系统评价与主题综合
BMC Med Ethics. 2016 Nov 10;17(1):73. doi: 10.1186/s12910-016-0153-x.
3
On moving targets and magic bullets: Can the UK lead the way with responsible data linkage for health research?关于移动目标与神奇子弹:英国能否在健康研究的负责任数据关联方面引领潮流?
Int J Med Inform. 2015 Nov;84(11):933-40. doi: 10.1016/j.ijmedinf.2015.08.011. Epub 2015 Aug 24.
4
Factors influencing effective data sharing between health care and social care regarding the care of older people: a qualitative evidence synthesis.影响医疗保健和社会保健之间老年人护理方面有效数据共享的因素:定性证据综合分析。
Health Soc Care Deliv Res. 2024 May;12(12):1-87. doi: 10.3310/TTWG4738.
5
Sharing real-world data for public benefit: a qualitative exploration of stakeholder views and perceptions.为公共利益共享真实世界数据:利益相关者观点和看法的定性探索。
BMC Public Health. 2023 Jan 19;23(1):133. doi: 10.1186/s12889-023-15035-w.
6
Tightrope walking towards maximising secondary uses of digitised health data: a qualitative study.迈向数字化健康数据二次利用最大化的平衡之举:一项定性研究
J Innov Health Inform. 2016 Oct 12;23(3):847. doi: 10.14236/jhi.v23i3.847.
7
Governance and oversight of researcher access to electronic health data: the role of the Independent Scientific Advisory Committee for MHRA database research, 2006-2015.研究人员获取电子健康数据的治理与监督:药品和医疗产品监管局数据库研究独立科学咨询委员会的作用,2006 - 2015年
J R Coll Physicians Edinb. 2017 Mar;47(1):24-29. doi: 10.4997/JRCPE.2017.106.
8
Investigating the Extent to Which Patients Should Control Access to Patient Records for Research: A Deliberative Process Using Citizens' Juries.调查患者在多大程度上应控制用于研究的患者记录的访问权限:使用公民陪审团的审议过程
J Med Internet Res. 2018 Mar 28;20(3):e112. doi: 10.2196/jmir.7763.
9
The use of electronic patient records for medical research: conflicts and contradictions.电子病历在医学研究中的应用:冲突与矛盾
BMC Health Serv Res. 2015 Mar 29;15:124. doi: 10.1186/s12913-015-0783-6.
10
Patient Perspectives on Sharing Anonymized Personal Health Data Using a Digital System for Dynamic Consent and Research Feedback: A Qualitative Study.患者对使用数字系统进行动态同意和研究反馈来共享匿名个人健康数据的看法:一项定性研究
J Med Internet Res. 2016 Apr 15;18(4):e66. doi: 10.2196/jmir.5011.

引用本文的文献

1
Enhancing Ophthalmic Diagnosis and Treatment with Artificial Intelligence.利用人工智能提升眼科诊断与治疗水平。
Medicina (Kaunas). 2025 Feb 28;61(3):433. doi: 10.3390/medicina61030433.
2
Generalisable Overview of Study Risk for Lead Investigators Needing Guidance (GOSLING): A data governance risk tool.适用于需要指导的主要研究者的研究风险概述(GOSLING):一个数据治理风险工具。
PLoS One. 2024 Aug 20;19(8):e0309308. doi: 10.1371/journal.pone.0309308. eCollection 2024.
3
Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review.乳腺癌的直接和间接成本及其相关影响:系统评价。
Adv Ther. 2024 Jul;41(7):2700-2722. doi: 10.1007/s12325-024-02893-y. Epub 2024 Jun 4.

本文引用的文献

1
The real-world impact of National Institute for Health and Care Excellence's real-world evidence framework.英国国家卫生与临床优化研究所真实世界证据框架的现实世界影响。
J Comp Eff Res. 2023 Nov;12(11):e230135. doi: 10.57264/cer-2023-0135. Epub 2023 Oct 19.
2
Sharing real-world data for public benefit: a qualitative exploration of stakeholder views and perceptions.为公共利益共享真实世界数据:利益相关者观点和看法的定性探索。
BMC Public Health. 2023 Jan 19;23(1):133. doi: 10.1186/s12889-023-15035-w.
3
Health technology assessment: a framework.卫生技术评估:一个框架。
RMD Open. 2020 Nov;6(3). doi: 10.1136/rmdopen-2020-001289.
4
Big data in digital healthcare: lessons learnt and recommendations for general practice.数字医疗中的大数据:全科医学的经验教训和建议。
Heredity (Edinb). 2020 Apr;124(4):525-534. doi: 10.1038/s41437-020-0303-2. Epub 2020 Mar 5.
5
Artificial intelligence in healthcare: past, present and future.人工智能在医疗保健中的应用:过去、现在和未来。
Stroke Vasc Neurol. 2017 Jun 21;2(4):230-243. doi: 10.1136/svn-2017-000101. eCollection 2017 Dec.
6
Evidence for Health Decision Making - Beyond Randomized, Controlled Trials.健康决策的证据——超越随机对照试验
N Engl J Med. 2017 Aug 3;377(5):465-475. doi: 10.1056/NEJMra1614394.
7
What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews.什么是真实世界数据?基于文献和利益相关者访谈的定义综述。
Value Health. 2017 Jul-Aug;20(7):858-865. doi: 10.1016/j.jval.2017.03.008. Epub 2017 May 11.
8
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.在没有随机试验时使用大数据模拟目标试验。
Am J Epidemiol. 2016 Apr 15;183(8):758-64. doi: 10.1093/aje/kwv254. Epub 2016 Mar 18.
9
A systematic review of barriers to data sharing in public health.一项关于公共卫生领域数据共享障碍的系统综述。
BMC Public Health. 2014 Nov 5;14:1144. doi: 10.1186/1471-2458-14-1144.
10
Observational and interventional study design types; an overview.观察性和干预性研究设计类型;概述。
Biochem Med (Zagreb). 2014;24(2):199-210. doi: 10.11613/BM.2014.022. Epub 2014 Jun 15.